2019
DOI: 10.21608/ejh.2019.13228.1122
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation of bone marrow-derived mesenchymal stem cells into cardiomyocytes using different regimens of 5- azacytidine

Abstract: Background: Conventional therapeutic approaches for ischemic heart disease have limited benefit in preventing postischemic heart failure. Therefore, stem cell therapy emerges as a hopeful tool for treatment of ischemic heart disease following myocardial infarction. Aim: To standardize a protocol ensuring the best differentiation of bone marrow mesenchymal stem cells (BM-MSCs) into cardiomyocytes by using 5-azacytidine with minimum toxicity. Materials and Methods: BM-MSCs were isolated from the bone marrow of a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 40 publications
(45 reference statements)
0
0
0
Order By: Relevance